79results about How to "Avoid insufficient purity" patented technology

Process for producing nanomaterials such as graphenes, graphene composites, magnesium oxide, magnesium hydroxides and other nanomaterials by high heat vaporization and rapid cooling. In some of the preferred embodiments, the high heat is produced by an oxidation-reduction reaction of carbon dioxide and magnesium as the primary reactants, although additional materials such as reaction catalysts, control agents, or composite materials can be included in the reaction, if desired. The reaction also produces nanomaterials from a variety of other input materials, and by varying the process parameters, the type and morphology of the carbon nanoproducts and other nanoproducts can be controlled. The reaction products include novel nanocrystals of MgO (percilase) and MgAl2O4 (spinels) as well as composites of these nanocrystals with multiple layers of graphene deposited on or intercalated with them.

A process for mutual separation of platinum group metals (PGM), wherein highly stable compounds and steps are used to efficiently remove impurity elements while preventing increase of impurity content relative to that of the PGM in the mother liquor and also preventing decomposition of a chloro complex, and palladium, platinum, iridium, ruthenium and rhodium are separated mutually in such a way that each of the separated PGM has a sufficient purity to be a commercial product. A process for mutual separation of PGM, comprising the first step for leaching a raw material containing PGM and impurity elements, second step for removing the impurity elements from the leach liquor by solvent extraction, third step for recovering palladium from the raffinate, fourth step for removing cationic impurity elements from the raffinate by solvent extraction, fifth step for recovering platinum from the raffinate by hydrolysis, sixth step for recovering ruthenium from the precipitate by leaching, and seventh step for recovering iridium by solvent extraction to prepare the stripping liquor containing iridium and raffinate containing rhodium.

The invention provides methods and compositions for separating impurities during the manufacture of immunoglobulin (Ig) fusion proteins. Examples of impurities which may be removed in accordance with the methods of the invention include inactive forms of the Ig fusion protein and / or aggregates.

The invention relates to a method and equipment with which an organic solution extraction solution is purified from entrainment of aqueous solution and impurities during hydrometallurgical liquid-liquid extraction. The method treats an organic extraction solution, which is loaded with a valuable metal or valuable substance from the aqueous solution. The purpose is to carry out the physical separation of water droplets and the chemical removal of impurities from the organic extraction solution simultaneously.

The invention relates to the recovery of deoxy sugars, such as fucose from biomass-derived solutions, such as spent liquors obtained from pulping processes. The invention is based on the use of chromatographic fractionation with specific column packing materials and combinations thereof. The deoxy sugar product obtained from the chromatographic fractionation may be further purified by crystallization. The invention also provides a novel crystalline fucose product and a novel process for the crystallization of fucose.

The invention relates to a method and equipment with which an organic solution extraction solution is purified from entrainment of aqueous solution and impurities during hydrometallurgical liquid-liquid extraction. The method treats an organic extraction solution, which is loaded with a valuable metal or valuable substance from the aqueous solution. The purpose is to carry out the physical separation of water droplets and the chemical removal of impurities from the organic extraction solution simultaneously.

Methods of using Th-226 or mother radionuclides thereof, namely U-230 or Th-226, in medicine. These radionuclides are particularly appropriate for the treatment of human and / or non-human mammals, in particular for therapeutic, diagnostic (detection / imaging), prophylactic and pain palliation purposes. These radionuclides may be used in various forms for treatment and / or diagnostic purposes, in particular in cationic form or in the form of radioconjugates or bone-targeting complexes. Methods of making such radionuclides.

The present invention relates to a polyvinylidene fluoride preparation method, which comprises: introducing an acyl halide solution dispersed in a fluorine-containing organic solvent into a reaction kettle, adding a mixed solution comprising an inorganic alkali solution and hydrogen peroxide, carrying out a stirring reaction for 30-120 min at a temperature of -10-10 DEG C, carrying out in situ synthesis to obtain an initiator, introducing an aqueous solution of a dispersing agent, a vinylidene fluoride monomer and a chain transfer agent, carrying out a stirring reaction for 4-12 h at a temperature of 10-30 DEG C to prepare polyvinylidene fluoride, and carrying out filtering, washing, drying and crushing after completing the reaction to obtain the powdery product which is polyvinylidene fluoride resin powder. The powdery polyvinylidene fluoride resin has characteristics of good thermal stability, good physical property, good mechanical property, simple reaction process and easy control, and is suitable for industrial production.

A cuttings processing system processes return fluid recovered while drilling a wellbore at an offshore location. The processing system includes a separator having an inlet receiving the return fluid, an accelerator coupled to the inlet that accelerates the return fluid, and a conical spinning member that receives the accelerated return fluid from the accelerator and applies a centrifugal force to the return fluid. The acceleration provides the return fluid with a tangential velocity that substantially matches the rotational speed of the conical spinning member. The separator also has a liquid discharge port that discharging the substantially liquid component to a tank or pipe and a solids discharge opening that discharges the substantially solid component out of the separator. In one embodiment, a conveyance device transports the solids component from the separator to a selected location on the offshore facility.

The invention relates to bivalent bispecific monoclonal antibodies (bbmAb) or variants thereof, and methods of manufacturing such antibodies by co-expressing modified Fc-mutated derivatives of two different monoclonal antibodies in mammalian cell lines.

Process for producing nanomaterials such as graphenes, graphene composites, magnesium oxide, magnesium hydroxides and other nanomaterials by high heat vaporization and rapid cooling. In some of the preferred embodiments, the high heat is produced by an oxidation-reduction reaction of carbon dioxide and magnesium as the primary reactants, although additional materials such as reaction catalysts, control agents, or composite materials can be included in the reaction, if desired. The reaction also produces nanomaterials from a variety of other input materials, and by varying the process parameters, the type and morphology of the carbon nanoproducts and other nanoproducts can be controlled. The reaction products include novel nanocrystals of MgO (percilase) and MgAl2O4 (spinels) as well as composites of these nanocrystals with multiple layers of graphene deposited on or intercalated with them.

Process for producing nanomaterials such as graphenes, graphene composites, magnesium oxide, magnesium hydroxides and other nanomaterials by high heat vaporization and rapid cooling. In some of the preferred embodiments, the high heat is produced by an oxidation-reduction reaction of carbon dioxide and magnesium as the primary reactants, although additional materials such as reaction catalysts, control agents, or composite materials can be included in the reaction, if desired. The reaction also produces nanomaterials from a variety of other input materials, and by varying the process parameters, the type and morphology of the carbon nanoproducts and other nanoproducts can be controlled. The reaction products include novel nanocrystals of MgO (percilase) and MgAl2O4 (spinels) as well as composites of these nanocrystals with multiple layers of graphene deposited on or intercalated with them.

A process for producing organic peroxide initiators useful in the polymerization of ethylenically unsaturated monomers. The process for making the organic peroxides includes forming an aqueous emulsion of the organic peroxide. The organic peroxide is dispersed as small droplets of from 1 to 10 microns in size in the aqueous emulsion. The organic peroxide may be added to a polymerization reactor containing an ethylenically unsaturated monomer. The organic peroxide functions as a free radical initiator to polymerize the monomer. The organic peroxide may be substantially free of organic solvents and plasticizers. The resulting polymers are of high quality.

Dispersible powder compositions suitable for inhalation are disclosed, the compositions including a human interleukin mutein (mhIL-4).

The present invention relates to a method for purifying triple-helical or collagen-like proteins recombinantly produced from a bacterial, yeast or plant host cell.

Novel acylglycerides are disclosed comprising mono-, di- and triacylglycerides characterized by predominantly containing the conjugated linoleic acids t9,c11- and c10,t12 octadecadienoic acids to the exclusion of 11,13-, 8,10- and trans,trans isomers.

A process for producing organic peroxide initiators useful in the polymerization of ethylenically unsaturated monomers. The process for making the organic peroxides includes forming an aqueous emulsion of the organic peroxide. The organic peroxide is dispersed as small droplets of from 1 to 10 microns in size in the aqueous emulsion. The organic peroxide may be added to a polymerization reactor containing an ethylenically unsaturated monomer. The organic peroxide functions as a free radical initiator to polymerize the monomer. The organic peroxide may be substantially free of organic solvents and plasticizers. The resulting polymers are of high quality.